英特尔宣布加入埃隆·马斯克旗下Terafab人工智能芯片项目的消息虽未披露具体数据，但具有明确的象征意义。Benchmark分析师科迪·阿克里指出，鉴于Terafab项目尚处早期阶段，投资者应避免过度推算该代工业务的短期收入贡献。不过从股价层面看，这一表态的价值不容忽视。
阿克里认为，此次合作相当于外部验证，表明英特尔18A制程技术和制造执行已取得足够进展，使其能够重新参与先进制程领域的讨论。此次官宣标志着英特尔在高端芯片对话中重获话语权，尽管具体财务影响尚待观察。
（本文根据市场信息综合分析）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.